|
Vitae Pharmaceuticals is a privately-held company that has raised more than
$90 million in capital from top-tier venture firms, strategic corporate investors
and a number of highly successful individuals. Vitae’s investors include
Prospect Venture Partners,
Venrock Associates,
New Enterprise Associates,
Atlas Venture,
Wellcome Trust,
Boehringer Ingelheim,
GlaxoSmithKline,
Intel Capital and
Allergan Corporation.
[back to top] |
